ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)

Last updated: December 9, 2021
Sponsor: Ramsay Générale de Santé
Overall Status: Active - Recruiting

Phase

N/A

Condition

Endometriosis

Female Hormonal Deficiencies/abnormalities

Severe Premenstrual Symptom

Treatment

N/A

Clinical Study ID

NCT05153512
2018-A01354-51
  • Ages 12-20
  • Female

Study Summary

To date, no MRI study has been published describing the prevalence of endometriosis in adolescent girls, not even in those with significant dysmenorrhea and therefore more particularly at risk. Likewise, there are no precise data on the type of superficial or early-onset deep endometriosis that appears in adolescence. The collection of these data would allow an earlier diagnosis, because it is better documented, of endometriosis. The lesions would then be treated earlier, avoiding their development and the problems of infertility related to this pathology. The aim of this sudy is to assess the prevalence of endometriosis and its phenotypic representation in the study population consulting for dysmenorrhea with suspected endometriosis.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Patient aged between 12 and 20 years old.
  • After menarche.
  • Requiring pelvic MRI for exploration of dysmenorrhea (after or not ultrasound), in thecase of patients with suspected endometriosis, or for any other reason (cyst, tumor,non-obstructive urogenital malformations), in the case of patients without symptomsclinic associated with endometriosis.
  • Patient affiliated or beneficiary of a social security scheme.
  • Patient and her legal representative, if applicable, having been informed and notopposing this research.

Exclusion

Exclusion Criteria:

  • Patient whose pelvic MRI is performed as part of an exploration of obstructive uterinemalformations.
  • Patient claustrophobic, making it impossible to perform an MRI.
  • Contraindication to MRI: pacemaker, ferromagnetic object incompatible with MRI.
  • Pregnant, breastfeeding or parturient woman.
  • Protected patient: Major under guardianship, curatorship or other legal protection,deprived of liberty by judicial or administrative decision; Hospitalized withoutconsent.

Study Design

Total Participants: 350
Study Start date:
September 26, 2019
Estimated Completion Date:
December 26, 2021

Connect with a study center

  • BLOMET clinic

    Paris, IDF 75015
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.